Vaughan Nelson Investment Management L.P. Invests $43.02 Million in Acadia Healthcare Company, Inc. $ACHC

Vaughan Nelson Investment Management L.P. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 1,839,125 shares of the company’s stock, valued at approximately $43,017,000. Vaughan Nelson Investment Management L.P. owned about 2.00% of Acadia Healthcare at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP lifted its position in Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares during the period. Abrams Bison Investments LLC raised its holdings in Acadia Healthcare by 22.3% during the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after buying an additional 800,000 shares during the last quarter. Finally, UBS Group AG raised its holdings in Acadia Healthcare by 8.8% during the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $24.87 on Monday. The company’s fifty day moving average price is $25.49 and its 200-day moving average price is $20.34. The stock has a market cap of $2.29 billion, a PE ratio of -2.03, a price-to-earnings-growth ratio of 8.30 and a beta of 0.69. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same period last year, the business earned $0.40 EPS. Acadia Healthcare’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. UBS Group boosted their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Royal Bank Of Canada upped their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Finally, Guggenheim increased their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $26.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.